Chemistry:Drug Identification Number
Any product defined as a drug under the Canada Food and Drugs Act must have an associated Drug Identification Number (or DIN).[citation needed] A DIN also pertains to veterinary drugs permitted for sale in Canada.[1]
The Drug Identification Number (DIN) is the 8 digit number located on the label of prescription and over-the-counter drug products that have been evaluated by the Therapeutic Products Directorate (TPD) and approved for sale in Canada.[citation needed]
Once a drug has been approved, the Therapeutic Products Directorate issues a DIN, which permits the manufacturer to market the drug in Canada. For drugs, where there is minimal market history in Canada, there is a more stringent review and the drug is required to have a Notice of Compliance and a DIN in order to be marketed in Canada.[citation needed]
A DIN lets the user know that the product has undergone and passed a review of its formulation, labeling, and instructions for use. A drug product sold in Canada without a DIN is not in compliance with Canadian law, with limited exceptions, such as foreign drug products imported under emergency authorization.[2][3]
The DIN is also a tool to help in the follow-up of products on the market, recall of products, inspections, and quality monitoring. A drug product can be looked up via its DIN with the Health Canada's Drug Product Database (DPD) to find specific information of drugs approved by the Ministry.[4]
See also
- National Drug Code
United States - Pharmaceutical code
References
- ↑ "Vaccine and Drug Use Policy". Canadian Pork Council. https://www.cpc-ccp.com/drug-use-policy. Retrieved 5 July 2019.
- ↑ "Drug Identification Number (DIN)". Government of Canada. 8 January 2001. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fact-sheets/drug-identification-number.html. Retrieved 20 June 2021.
- ↑ "Importing and exporting health products for commercial use (GUI-0117)". Government of Canada. 23 December 2020. https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/importation-exportation/commercial-use-health-products-guidance/document.html#sec62. Retrieved 20 June 2021.
- ↑ Michael Gabay (10 March 2015). The Clinical Practice of Drug Information. Jones & Bartlett Publishers. pp. 53–. ISBN 978-1-284-02623-8. https://books.google.com/books?id=ZH6HCgAAQBAJ&pg=PA53.
External links
 |
